A vaccine design approach that could protect against new variants of SARS-CoV-2 (the virus that causes COVID-19) but also potentially protects against other coronaviruses is one step closer to reality as a result of Penn ...
Oct 18, 2022
0
170
Scientists have discovered a mutation in SARS-CoV-2, the virus that causes COVID-19, that plays a key role in its ability to infect the central nervous system. The findings may help scientists understand its neurological ...
Aug 23, 2024
0
99
The delta variant of SARS-CoV-2 has swept the planet, becoming the dominant variant within just a few months. A new study from Boston Children's Hospital, published in Science, explains why delta spreads so easily and infects ...
Nov 23, 2021
2
146
Millions have died due to COVID-19 infection, and millions more continue experiencing the chronic condition, Long COVID, which makes discovering practical, accessible, and powerful SARS-CoV-2 preventatives and COVID-19 treatments ...
Nov 11, 2022
0
11
Getting sick with a common cold doesn't make you immune to COVID-19, but a COVID-19 infection might, at least temporarily, boost the number of antibodies you have against common cold-causing coronaviruses and the SARS-CoV-1 ...
May 5, 2022
0
110
A group of bat viruses related to SARS-CoV-2 can also infect human cells but uses a different and unknown entryway.
Apr 8, 2022
0
102
A new protein-based antiviral nasal spray developed by researchers at Northwestern University, University of Washington and Washington University at St. Louis is being advanced toward Phase I human clinical trials to treat ...
Apr 13, 2022
0
155
An entirely new approach to monoclonal antibody therapy shows that targeting the more genetically stable internal protein of the SARS-CoV-2 virus rather than the surface spike protein can also clear SARS-CoV-2, reports a ...
Oct 14, 2022
0
60
Scientists at Scripps Research, IAVI, the Ragon Institute and Moderna, Inc., have come together to make critical advances in developing an effective vaccine against human immunodeficiency virus (HIV).
Oct 3, 2022
0
56
A major clinical trial, led by experts at the University of Nottingham working in partnership with several universities and NHS hospitals, has found that interrupting the treatment of vulnerable people on long-term immune-suppressing ...
Jun 27, 2022
0
59
